Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00297141
Status:
COMPLETED
Last Update Posted:
2013-12-31
First Post:
2006-02-27
Brief Title:
Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma
Sponsor:
Austrian Breast Colorectal Cancer Study Group
Organization:
Austrian Breast Colorectal Cancer Study Group
Study Overview
Official Title:
Preoperative Combined Radiochemotherapy for Patients With Newly Diagnosed Primary Operable and Locally Advanced Rectal Carcinoma cT3 Nx M0 of the Lower and Middle Rectum
Status:
COMPLETED
Status Verified Date:
2013-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Rate of T-downstaging Reduction of the T-stadium at the time of final surgery following the preoperative combined radiochemotherapy chemotherapy Oxaliplatin Capecitabine Evaluation of the toxicity grade III and IV of the therapy scheme
Detailed Description:
About 60 patients with locally advanced rectal carcinoma cT3 Nx M0 of the lower and middle rectum will be recruited
The radiotherapy is an essential part of therapy of the advanced rectal carcinoma and the additional administration of a chemotherapy will positively influence the effect of the therapy downstaging-rate rate of distant metastases survival-rate Probably a downsizing and downstaging as per literature and by own experience can be reached with an preoperative combined radiochemotherapy
The radiotherapy is an essential part of therapy of the advanced rectal carcinoma and the additional administration of a chemotherapy will positively influence the effect of the therapy downstaging-rate rate of distant metastases survival-rate Probably a downsizing and downstaging as per literature and by own experience can be reached with an preoperative combined radiochemotherapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004-002358-72 | EUDRACT_NUMBER | ABCSG internal study code | None |
| Studie R02 95 | OTHER | None | None |